• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,914.96 436.29
( 0.57%)
Global Indices
Nasdaq
52,316.93 113.19
(0.22%)
Dow Jones
7,516.83 55.40
(0.74%)
Hang Seng
70,280.54 812.43
(1.17%)
Nikkei 225
10,511.26 27.04
(0.26%)
Forex
USD-INR
94.49 0.37
(0.39%)
EUR-INR
107.78 0.64
(0.60%)
GBP-INR
125.01 0.85
(0.69%)
JPY-INR
0.58 0.00
(0.33%)

EQUITY - MARKET SCREENER

Divis Laboratories Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
532488
INE361B01024
629.4942217
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
DIVISLAB
65.59
174618.6
EPS(TTM)
Face Value()
Div & Yield %
100.29
2
0.46
 

Indian Sucrose standalone net profit declines 27.55% in the March 2026 quarter
Jun 06,2026
Net profit of Indian Sucrose declined 27.55% to Rs 26.09 crore in the quarter ended March 2026 as against Rs 36.01 crore during the previous quarter ended March 2025. Sales declined 1.36% to Rs 308.22 crore in the quarter ended March 2026 as against Rs 312.46 crore during the previous quarter ended March 2025.

For the full year,net profit declined 18.99% to Rs 31.09 crore in the year ended March 2026 as against Rs 38.38 crore during the previous year ended March 2025. Sales declined 6.40% to Rs 510.77 crore in the year ended March 2026 as against Rs 545.69 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales308.22312.46 -1 510.77545.69 -6
OPM %18.8917.44 -15.4013.43 -
PBDT57.8152.41 10 72.6563.17 15
PBT53.6549.42 9 60.5352.62 15
NP26.0936.01 -28 31.0938.38 -19